A strict new vaccine approval process in the U.S. could dramatically slow things down for biopharma and the public, experts ...
As 2025 ends, delve into some biotech feel-good stories where the right treatment meets the right patient, almost feeling ...
It’s the holiday season, and what’s better to do than cuddle up in bed and watch a movie? We want to make sure you’re not missing out on some binge-worthy biotech movies this December. So, we have ...
Take a look back into biotech in 2025 as the year is closing - from GLP-1s to radiopharmaceuticals and neuroplastogens.
BIO-Europe Startup Spotlight returns to Lisbon in March 2026, showcasing Europe’s top early-stage biotech pitches to industry leaders.
Asking whether China is the future of the biotech industry might seem counterintuitive, considering the current biotech geopolitical context. If you haven’t followed this series of events, a ...
The OECD recently published an update on key biotechnology indicators, an opportunity for us to delve into the top-performing countries in the field. With the highest number of active biotech ...
Aiolos Bio has emerged as a significant player in the biopharmaceutical industry, with a focus on developing treatments for respiratory and inflammatory diseases. The company’s launch in 2023, backed ...
The news that the organization led a $35 million funding round for London-based Portal Biotech came about two weeks ago. Portal Biotech’s focus is on the field of proteomics, which is the study of ...
Migraines are not simply a bad headache; they are a neurological disorder that can significantly impact daily life. Often characterized by throbbing pain on one side of the head, they can be moderate ...
Discovered in the late 1990s, Small interfering RNA (siRNA) is a class of double-stranded RNA molecules, involved in the RNA interference (RNAi) pathway, where it mediates the silencing of specific ...
Once a booming field, bustling with innovation and money driving that innovation, the cell and gene therapy sector is now struggling to fuel therapeutic growth to bring medicines to patients. It doesn ...